ANCC Family Nurse Practitioner FNP Board Exam Actual
Exam 2026/2027 | Questions with Verified Answers |
100% Correct | Pass Guaranteed
SECTION 1: Health Promotion & Disease Prevention
Q1: A 55-year-old woman presents for a wellness visit. She has no personal history of
breast cancer, BRCA mutation, or chest irradiation. Her mother was diagnosed with
post-menopausal breast cancer at age 68. According to 2024 USPSTF guidelines, which
screening recommendation is MOST appropriate?
A. Begin biennial mammography now (Grade A)
B. Begin annual MRI and mammography now (Grade B)
C. Begin biennial mammography at age 60 (Grade C)
D. Defer screening until age 60 unless she requests earlier (Grade D)
Correct Answer: A
Rationale: USPSTF Grade A recommends biennial mammography for women 50–74
with average risk; family history of post-menopausal breast cancer does not alter
interval. Annual MRI (B) is reserved for high-risk (BRCA, >20 % lifetime risk). Waiting
until 60 (C, D) delays evidence-based screening.
Q2: A 16-year-old presents for a sports physical. Immunization records show completed
PCV-13 series, meningococcal conjugate at 11 years, Tdap at 12 years, and two-dose
HPV series at 11 and 13 years. Which vaccine is indicated TODAY?
,A. HPV #3 (0, 1–2, 6 month schedule)
B. Meningococcal B (2-dose series)
C. Meningococcal conjugate #2 (booster at 16 y)
D. Tdap booster
Correct Answer: C
Rationale: ACIP recommends a booster dose of meningococcal conjugate (MenACWY)
at 16 years to maintain protection through age 18–21. HPV series is complete with two
doses <15 y (A). MenB (B) is optional (Category B) and not required for school. Tdap (D)
is every 10 years; next due at 22 y.
Q3: A 45-year-old man with BMI 32 kg/m², BP 128/82, and no diabetes asks about statin
therapy. His 10-year ASCVD risk is 6.8 %. Which USPSTF recommendation applies?
A. Offer moderate-intensity statin (Grade B)
B. Defer statin; repeat risk at age 50 (Grade I)
C. Offer high-intensity statin (Grade A)
D. Counsel lifestyle only (Grade D)
Correct Answer: A
Rationale: For adults 40–75 with ≥1 CVD risk factor (dyslipidemia, HTN, smoking,
diabetes) and ≥7.5 % 10-year risk, USPSTF Grade B recommends moderate-intensity
statin. His risk is borderline; shared decision-making favors initiation. High-intensity (C)
is for ASCVD or LDL ≥190. Lifestyle (D) is insufficient monotherapy at this risk level.
,Q4: A 24-year-old woman is newly sexually active with one male partner, uses condoms
inconsistently, and denies STI history. Which screening test is indicated TODAY?
A. HIV (Grade A) and chlamydia/gonorrhea (Grade A)
B. Syphilis only (Grade B)
C. Hepatitis C (Grade B)
D. Trichomonas (Grade I)
Correct Answer: A
Rationale: USPSTF Grade A: annual chlamydia/gonorrhea screening for all sexually
active women ≤24 y; HIV at least once for adolescents/adults 15–65 y. Syphilis (B) is
risk-based. Hep C (C) is one-time for adults 18–79, not specifically tied to sexual
activity. Trichomonas (D) evidence insufficient.
Q5: A 70-year-old woman with 40 pack-year history quit smoking 5 years ago. She asks
about lung-cancer screening. Which statement is CORRECT?
A. Annual LDCT is indicated (Grade B) for 3 years only
B. Screening stops at age 77 (Grade B)
C. Chest X-ray is acceptable alternative (Grade C)
D. No further screening since she quit >5 y ago
Correct Answer: B
Rationale: USPSTF/NLST: annual LDCT ages 50–80 with ≥20 pack-years and ≤15 y
since quit. Screening stops when patient reaches 80 y or >15 y since quit; thus 77 y is
, last eligible year. LDCT is not limited to 3 years (A). Chest X-ray (C) is ineffective (no
mortality benefit). She remains eligible because quit <15 y (D).
Q6: A 30-year-old G2P1 at 12 weeks gestation asks about cell-free DNA (NIPT) versus
first-trimester combined screen for aneuploidy. Which counseling is evidence-based?
A. NIPT is recommended for ALL pregnancies (Grade A)
B. Either test acceptable; NIPT has higher sensitivity for trisomy 21 (Grade A)
C. First-trimester combined screen preferred in twin gestations
D. NIPT should be deferred until 16 weeks
Correct Answer: B
Rationale: ACOG 2023: NIPT or first-trimester combined screen offered to all; NIPT has
>99 % sensitivity for T21 versus 85 % for combined screen. Universal recommendation
(A) is not mandated; shared decision-making. NIPT is valid in twins (C) with slightly
lower accuracy. Optimal NIPT window is 10–13 weeks (D).
Q7: A 8-month-old infant is brought for a well-child visit. Which developmental screening
tool is MOST validated for use at this age?
A. M-CHAT (18–30 mo)
B. ASQ-3 (1–66 mo)
C. PHQ-9 (adults)
D. Denver II (obsolete)
Correct Answer: B
Exam 2026/2027 | Questions with Verified Answers |
100% Correct | Pass Guaranteed
SECTION 1: Health Promotion & Disease Prevention
Q1: A 55-year-old woman presents for a wellness visit. She has no personal history of
breast cancer, BRCA mutation, or chest irradiation. Her mother was diagnosed with
post-menopausal breast cancer at age 68. According to 2024 USPSTF guidelines, which
screening recommendation is MOST appropriate?
A. Begin biennial mammography now (Grade A)
B. Begin annual MRI and mammography now (Grade B)
C. Begin biennial mammography at age 60 (Grade C)
D. Defer screening until age 60 unless she requests earlier (Grade D)
Correct Answer: A
Rationale: USPSTF Grade A recommends biennial mammography for women 50–74
with average risk; family history of post-menopausal breast cancer does not alter
interval. Annual MRI (B) is reserved for high-risk (BRCA, >20 % lifetime risk). Waiting
until 60 (C, D) delays evidence-based screening.
Q2: A 16-year-old presents for a sports physical. Immunization records show completed
PCV-13 series, meningococcal conjugate at 11 years, Tdap at 12 years, and two-dose
HPV series at 11 and 13 years. Which vaccine is indicated TODAY?
,A. HPV #3 (0, 1–2, 6 month schedule)
B. Meningococcal B (2-dose series)
C. Meningococcal conjugate #2 (booster at 16 y)
D. Tdap booster
Correct Answer: C
Rationale: ACIP recommends a booster dose of meningococcal conjugate (MenACWY)
at 16 years to maintain protection through age 18–21. HPV series is complete with two
doses <15 y (A). MenB (B) is optional (Category B) and not required for school. Tdap (D)
is every 10 years; next due at 22 y.
Q3: A 45-year-old man with BMI 32 kg/m², BP 128/82, and no diabetes asks about statin
therapy. His 10-year ASCVD risk is 6.8 %. Which USPSTF recommendation applies?
A. Offer moderate-intensity statin (Grade B)
B. Defer statin; repeat risk at age 50 (Grade I)
C. Offer high-intensity statin (Grade A)
D. Counsel lifestyle only (Grade D)
Correct Answer: A
Rationale: For adults 40–75 with ≥1 CVD risk factor (dyslipidemia, HTN, smoking,
diabetes) and ≥7.5 % 10-year risk, USPSTF Grade B recommends moderate-intensity
statin. His risk is borderline; shared decision-making favors initiation. High-intensity (C)
is for ASCVD or LDL ≥190. Lifestyle (D) is insufficient monotherapy at this risk level.
,Q4: A 24-year-old woman is newly sexually active with one male partner, uses condoms
inconsistently, and denies STI history. Which screening test is indicated TODAY?
A. HIV (Grade A) and chlamydia/gonorrhea (Grade A)
B. Syphilis only (Grade B)
C. Hepatitis C (Grade B)
D. Trichomonas (Grade I)
Correct Answer: A
Rationale: USPSTF Grade A: annual chlamydia/gonorrhea screening for all sexually
active women ≤24 y; HIV at least once for adolescents/adults 15–65 y. Syphilis (B) is
risk-based. Hep C (C) is one-time for adults 18–79, not specifically tied to sexual
activity. Trichomonas (D) evidence insufficient.
Q5: A 70-year-old woman with 40 pack-year history quit smoking 5 years ago. She asks
about lung-cancer screening. Which statement is CORRECT?
A. Annual LDCT is indicated (Grade B) for 3 years only
B. Screening stops at age 77 (Grade B)
C. Chest X-ray is acceptable alternative (Grade C)
D. No further screening since she quit >5 y ago
Correct Answer: B
Rationale: USPSTF/NLST: annual LDCT ages 50–80 with ≥20 pack-years and ≤15 y
since quit. Screening stops when patient reaches 80 y or >15 y since quit; thus 77 y is
, last eligible year. LDCT is not limited to 3 years (A). Chest X-ray (C) is ineffective (no
mortality benefit). She remains eligible because quit <15 y (D).
Q6: A 30-year-old G2P1 at 12 weeks gestation asks about cell-free DNA (NIPT) versus
first-trimester combined screen for aneuploidy. Which counseling is evidence-based?
A. NIPT is recommended for ALL pregnancies (Grade A)
B. Either test acceptable; NIPT has higher sensitivity for trisomy 21 (Grade A)
C. First-trimester combined screen preferred in twin gestations
D. NIPT should be deferred until 16 weeks
Correct Answer: B
Rationale: ACOG 2023: NIPT or first-trimester combined screen offered to all; NIPT has
>99 % sensitivity for T21 versus 85 % for combined screen. Universal recommendation
(A) is not mandated; shared decision-making. NIPT is valid in twins (C) with slightly
lower accuracy. Optimal NIPT window is 10–13 weeks (D).
Q7: A 8-month-old infant is brought for a well-child visit. Which developmental screening
tool is MOST validated for use at this age?
A. M-CHAT (18–30 mo)
B. ASQ-3 (1–66 mo)
C. PHQ-9 (adults)
D. Denver II (obsolete)
Correct Answer: B
